Why Is Halozyme Therapeutics (HALO) Down 13.1% Since Last Earnings Report?

A month has gone by since the last earnings report for Halozyme Therapeutics (HALO) . Shares have lost about 13.1% in that time frame, underperforming the S&P 500.But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Halozyme Therapeutics due for a breakout? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent drivers for Halozyme Therapeutics, Inc. before we dive into how inv ...